These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102. A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear. Hagsäter SM; Pettersson R; Pettersson C; Atanasovski D; Näslund J; Eriksson E Int J Neuropsychopharmacol; 2021 Sep; 24(9):749-757. PubMed ID: 34228806 [TBL] [Abstract][Full Text] [Related]
103. Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice. de la Fuente Revenga M; Shah UH; Nassehi N; Jaster AM; Hemanth P; Sierra S; Dukat M; González-Maeso J ACS Chem Neurosci; 2021 Mar; 12(5):831-844. PubMed ID: 33400504 [TBL] [Abstract][Full Text] [Related]
104. Structural basis of psychedelic LSD recognition at dopamine D Fan L; Zhuang Y; Wu H; Li H; Xu Y; Wang Y; He L; Wang S; Chen Z; Cheng J; Xu HE; Wang S Neuron; 2024 Oct; 112(19):3295-3310.e8. PubMed ID: 39094559 [TBL] [Abstract][Full Text] [Related]
105. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Vargas MV; Dunlap LE; Dong C; Carter SJ; Tombari RJ; Jami SA; Cameron LP; Patel SD; Hennessey JJ; Saeger HN; McCorvy JD; Gray JA; Tian L; Olson DE Science; 2023 Feb; 379(6633):700-706. PubMed ID: 36795823 [TBL] [Abstract][Full Text] [Related]
106. Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties. Puigseslloses P; Nadal-Gratacós N; Ketsela G; Weiss N; Berzosa X; Estrada-Tejedor R; Islam MN; Holy M; Niello M; Pubill D; Camarasa J; Escubedo E; Sitte HH; López-Arnau R Mol Psychiatry; 2024 Aug; 29(8):2346-2358. PubMed ID: 38486047 [TBL] [Abstract][Full Text] [Related]
108. Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures. Yao H; Wang X; Chi J; Chen H; Liu Y; Yang J; Yu J; Ruan Y; Xiang X; Pi J; Xu JF Molecules; 2024 Feb; 29(5):. PubMed ID: 38474476 [TBL] [Abstract][Full Text] [Related]
110. Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT Pottie E; Poulie CBM; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Kristensen JL; Stove CP ACS Chem Neurosci; 2023 Aug; 14(15):2727-2742. PubMed ID: 37474114 [TBL] [Abstract][Full Text] [Related]
111. 25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor. Märcher Rørsted E; Jensen AA; Kristensen JL ChemMedChem; 2021 Nov; 16(21):3263-3270. PubMed ID: 34288515 [TBL] [Abstract][Full Text] [Related]